180 related articles for article (PubMed ID: 26591311)
41. Advances in the diagnosis and control of lymphomas.
Candelaria M
Salud Publica Mex; 2016 Apr; 58(2):296-301. PubMed ID: 27557389
[TBL] [Abstract][Full Text] [Related]
42. Combination therapies in oncology.
Webster RM
Nat Rev Drug Discov; 2016 Feb; 15(2):81-2. PubMed ID: 26837588
[No Abstract] [Full Text] [Related]
43. Preface.
Berger FG; Boland CR
Adv Cancer Res; 2021; 151():xv-xvi. PubMed ID: 34148622
[No Abstract] [Full Text] [Related]
44. Biology and genetics of colorectal cancer.
Walker J; Quirke P
Eur J Cancer; 2001 Oct; 37 Suppl 7():S163-72. PubMed ID: 11887987
[No Abstract] [Full Text] [Related]
45. HORIZON I: Is there a future for oral anti-angiogenics on the horizon of colorectal cancer therapy?
Hochster HS
Br J Cancer; 2013 Feb; 108(3):477-8. PubMed ID: 23422787
[No Abstract] [Full Text] [Related]
46. Explaining the unexplainable: EGFR antibodies in colorectal cancer.
Grothey A; Lenz HJ
J Clin Oncol; 2012 May; 30(15):1735-7. PubMed ID: 22473160
[No Abstract] [Full Text] [Related]
47. Advances in mechanism and treatment strategy of cancer.
Zeng Y
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):1-3. PubMed ID: 29808792
[TBL] [Abstract][Full Text] [Related]
48. The bipartisan colon.
Hochster HS
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25713149
[No Abstract] [Full Text] [Related]
49. Colorectal cancer: new advances in immunotherapy.
Cubas R; Li M; Chen C; Yao Q
Cancer Biol Ther; 2007 Jan; 6(1):11-7. PubMed ID: 17224640
[TBL] [Abstract][Full Text] [Related]
50. What is the Current Role of Immunotherapy for Colon Cancer?
Galanternik F; Recondo G; Valsecchi ME; Greco M; Recondo G; de la Vega M; E Diaz Cantón
Rev Recent Clin Trials; 2016; 11(2):93-8. PubMed ID: 27028968
[TBL] [Abstract][Full Text] [Related]
51. Improved Outcomes in Metastatic Colon Cancer: Giving Credit Where Credit Is Due.
Sargent D
JAMA Oncol; 2015 Sep; 1(6):795-6. PubMed ID: 26181004
[No Abstract] [Full Text] [Related]
52. Future shock: embracing disruption in the immunotherapy revolution.
Alvarnas J
Am J Manag Care; 2018 Feb; 24(2 Spec No.):SP34. PubMed ID: 29689140
[No Abstract] [Full Text] [Related]
53. Innovative cancer therapies offer new hope.
Brody H
Nature; 2024 May; 629(8014):S1. PubMed ID: 38811701
[No Abstract] [Full Text] [Related]
54. [20 years of progress in dissecting mechanisms of oncogenesis. Relations between magic of science and requirements of medicine].
Janin N
Presse Med; 1996 Nov; 25(35):1669-71. PubMed ID: 8977577
[TBL] [Abstract][Full Text] [Related]
55. 2015 and human cancer: back to overall survival.
Ciccarese C; Massari F; Tortora G
Future Oncol; 2016 Aug; 12(15):1751-4. PubMed ID: 27007304
[No Abstract] [Full Text] [Related]
56. Colorectal cancer and dostarlimab - An episode in discovery to new era of immunotherapy.
Bethineedi LD; Simhachalam Kutikuppala LV; Boppana SH; Kuchana SK; Kalyani Ponnaganti SV
J Cancer Res Ther; 2023; 19(5):1490-1491. PubMed ID: 37787342
[No Abstract] [Full Text] [Related]
57. Ten recent advances that could not have come about without applying physiology.
Pinsky MR; Brochard L; Kellum JA
Intensive Care Med; 2016 Feb; 42(2):258-60. PubMed ID: 25805653
[No Abstract] [Full Text] [Related]
58. Colorectal Cancer-Recent Advances and Future Challenges.
Inadomi J; Jung B
Gastroenterology; 2020 Jan; 158(2):289-290. PubMed ID: 31926588
[No Abstract] [Full Text] [Related]
59. [The significance of ADAMTS in colorectal cancer and recent progress].
Wang Y; Xu EP
Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):824-828. PubMed ID: 31594054
[TBL] [Abstract][Full Text] [Related]
60. Debunking the Delusion That Precision Oncology Is an Illusion.
Subbiah V; Kurzrock R
Oncologist; 2017 Aug; 22(8):881-882. PubMed ID: 28550030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
